{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:59:00Z","timestamp":1793627940462,"version":"4.5.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB551"],"award-info":[{"award-number":["2020CFB551"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["cxpy2019074"],"award-info":[{"award-number":["cxpy2019074"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871752"],"award-info":[{"award-number":["81871752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301538"],"award-info":[{"award-number":["81301538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114669","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:10:12Z","timestamp":1625224212000},"page":"114669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["Parathyroid hormone and its related peptides in bone metabolism"],"prefix":"10.1016","volume":"192","author":[{"given":"Tianhong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuowen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114669_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ecl.2018.07.003","article-title":"Physiology of parathyroid hormone","volume":"47","author":"Goltzman","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"10.1016\/j.bcp.2021.114669_b0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/JPER.18-0639","article-title":"Intermittent parathyroid hormone promotes cementogenesis in a PKA- and ERK1\/2-dependent manner","volume":"90","author":"Xu","year":"2019","journal-title":"J. Periodontol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12891-017-1530-4","article-title":"Intermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats","volume":"18","author":"Chen","year":"2017","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbmr.3600","article-title":"IL-17 Receptor Signaling in Osteoblasts\/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production","volume":"34","author":"Li","year":"2019","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.bcp.2021.114669_b0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2015.07.007","article-title":"Osteoinduction of bone grafting materials for bone repair and regeneration","volume":"81","author":"Garcia-Gareta","year":"2015","journal-title":"Bone"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2021.114669_b0035","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-1383(13)70010-X","article-title":"Treatment of non-unions with bone defects: which option and why?","volume":"44","author":"Ashman","year":"2013","journal-title":"Injury"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cbf.3164","article-title":"The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB\/c mice","volume":"34","author":"Gohin","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2015.08.112","article-title":"Osteogenic growth peptide promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL13","volume":"466","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through beta-catenin","volume":"6","author":"Meng","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00223-013-9741-7","article-title":"Osteoclast-derived coupling factors in bone remodeling","volume":"94","author":"Henriksen","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0060","doi-asserted-by":"crossref","first-page":"e1905876","DOI":"10.1002\/smll.201905876","article-title":"Parathyroid hormone derivative with reduced osteoclastic activity promoted bone regeneration via synergistic bone remodeling and angiogenesis","volume":"16","author":"Huang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.bcp.2021.114669_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/164_2020_373","article-title":"Osteoporosis therapeutics 2020","author":"Kocijan","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bcp.2021.114669_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19877994","article-title":"Update on the safety and efficacy of teriparatide in the treatment of osteoporosis","volume":"11","author":"Minisola","year":"2019","journal-title":"Therapeut. Adv. Musculoskeletal Disease"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2021.114669_b0080","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jcot.2019.10.009","article-title":"Teriparatide for treating delayed union and nonunion: a systematic review","volume":"11","author":"Canintika","year":"2020","journal-title":"J. Clin. Orthop. Trauma"},{"issue":"8","key":"10.1016\/j.bcp.2021.114669_b0085","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.injury.2019.06.001","article-title":"Daily subcutaneous Teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study","volume":"50","author":"Wagner","year":"2019","journal-title":"Injury"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy","volume":"15","author":"Leder","year":"2017","journal-title":"Curr. Osteoporosis Rep."},{"key":"10.1016\/j.bcp.2021.114669_b0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2019.05.024","article-title":"Abaloparatide, the second generation osteoanabolic drug: molecular mechanisms underlying its advantages over the first-in-class teriparatide","volume":"166","author":"Bhattacharyya","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114669_b0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2018.05.024","article-title":"Withdrawal of parathyroid hormone after prolonged administration leads to adipogenic differentiation of mesenchymal precursors in vivo","volume":"118","author":"Balani","year":"2019","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jbmr.4188","article-title":"Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study","volume":"36","author":"Gilsenan","year":"2021","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.bcp.2021.114669_b0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2017.04.001","article-title":"Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1\u201334)","volume":"86","author":"Jolette","year":"2017","journal-title":"Regul. Toxicol. Pharmacol. RTP"},{"issue":"17","key":"10.1016\/j.bcp.2021.114669_b0115","doi-asserted-by":"crossref","first-page":"e6637","DOI":"10.1097\/MD.0000000000006637","article-title":"Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.bcp.2021.114669_b0120","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1021\/acsbiomaterials.7b00780","article-title":"Bone regeneration induced by local delivery of a modified PTH-derived peptide from nanohydroxyapatite\/chitosan coated true bone ceramics","volume":"4","author":"Yang","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jbm.a.36802","article-title":"Ectopic osteogenesis by type I collagen loaded with a novel synthesized PTH-related peptide-1 in vivo","volume":"108","author":"Wang","year":"2020","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"22","key":"10.1016\/j.bcp.2021.114669_b0130","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1039\/C8RA00870A","article-title":"Local delivery of a novel PTHrPviamesoporous bioactive glass scaffolds to improve bone regeneration in a rat posterolateral spinal fusion model","volume":"8","author":"Liang","year":"2018","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.bcp.2021.114669_b0135","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.tem.2019.07.011","article-title":"PTH\/PTHrP receptor signaling, allostery, and structures","volume":"30","author":"Sutkeviciute","year":"2019","journal-title":"Trends Endocrinol. Metab.: TEM"},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","article-title":"IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0145","doi-asserted-by":"crossref","first-page":"e00004","DOI":"10.1002\/prp2.4","article-title":"Green fluorescent protein fused to peptide agonists of two dissimilar G protein-coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor","volume":"1","author":"Charest-Morin","year":"2013","journal-title":"Pharmacol. Res. Perspect."},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1359-6446(05)03370-2","article-title":"Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors","volume":"10","author":"Hoare","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0155","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41589-020-0567-0","article-title":"Allosteric interactions in the parathyroid hormone GPCR-arrestin complex formation","volume":"16","author":"Clark","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1476-5381.2011.01450.x","article-title":"'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?","volume":"164","author":"Gesty-Palmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114669_b0165","first-page":"1896","article-title":"Parathyroid hormone activates phospholipase C (PLC)-independent protein kinase c signaling pathway via protein kinase A (PKA)-dependent mechanism: a new defined signaling route would induce alternative consideration to previous conceptions","volume":"23","author":"Tong","year":"2017","journal-title":"Med. Sci. Monitor Int. Med. J. Experiment. Clin. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0170","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jor.24075","article-title":"Parathyroid hormone for bone regeneration","volume":"36","author":"Wojda","year":"2018","journal-title":"J. Orthop. Res.Official Publ. Orthop. Res. Soc."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0175","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1074\/jbc.M115.679753","article-title":"Loss of gsalpha in the postnatal skeleton leads to low bone mass and a blunted response to anabolic parathyroid hormone therapy","volume":"291","author":"Sinha","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/pr.116.013367","article-title":"The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling","volume":"69","author":"Peterson","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2021.114669_b0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/jcs.03338","article-title":"Beta-arrestin signaling and regulation of transcription","volume":"120","author":"Ma","year":"2007","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tem.2016.10.007","article-title":"GPCR signaling and trafficking: the long and short of it","volume":"28","author":"Pavlos","year":"2017","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0195","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.1205756110","article-title":"Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gbetagamma complex","volume":"110","author":"Wehbi","year":"2013","journal-title":"PNAS"},{"issue":"13","key":"10.1016\/j.bcp.2021.114669_b0200","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1918158117","article-title":"Gq\/11-dependent regulation of endosomal cAMP generation by parathyroid hormone class B GPCR","volume":"117","author":"White","year":"2020","journal-title":"PNAS"},{"issue":"15","key":"10.1016\/j.bcp.2021.114669_b0205","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1074\/jbc.RA118.001737","article-title":"Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation","volume":"293","author":"Zhang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114669_b0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/B978-0-12-394440-5.00013-9","article-title":"Arrestins in bone","volume":"118","author":"Bohinc","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","article-title":"Parathyroid hormone directs bone marrow mesenchymal cell fate","volume":"25","author":"Fan","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0220","first-page":"190","article-title":"Stem cells: PTH regulates bone marrow progenitor fate, Nature reviews","volume":"13","author":"Holmes","year":"2017","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0225","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/jbmr.3811","article-title":"Parathyroid hormone shifts cell fate of a leptin receptor-marked stromal population from adipogenic to osteoblastic lineage","volume":"34","author":"Yang","year":"2019","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cellsig.2015.12.012","article-title":"Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase","volume":"28","author":"Larsson","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2021.114669_b0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biomaterials.2018.06.035","article-title":"Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats","volume":"179","author":"Jiang","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0240","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1096\/fj.201800948RR","article-title":"Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton","volume":"33","author":"Maridas","year":"2019","journal-title":"FASEB J. Official Publ. Federation Am. Soc. Experiment. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0245","first-page":"781","article-title":"Differential effects on bone and mesenchymal stem cells caused by intermittent and continuous PTH administration","volume":"98","author":"Zhang","year":"2018","journal-title":"Zhonghua yi xue za zhi"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0250","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/mt.2015.211","article-title":"PTH induces systemically administered mesenchymal stem cells to migrate to and regenerate spine injuries","volume":"24","author":"Sheyn","year":"2016","journal-title":"Mol. Therapy J. Am. Soc. Gene Therapy"},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0255","doi-asserted-by":"crossref","first-page":"e0226163","DOI":"10.1371\/journal.pone.0226163","article-title":"PTH1-34 improves bone healing by promoting angiogenesis and facilitating MSCs migration and differentiation in a stabilized fracture mouse model","volume":"14","author":"Jiang","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2021.114669_b0260","first-page":"259","article-title":"Effects of intermittent parathyroid hormone 1\u201334 administration on circulating mesenchymal stem cells in postmenopausal osteoporotic women","volume":"25","author":"Tang","year":"2019","journal-title":"Med. Sci. Monitor Int. Med. J. Experiment. Clin. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102221","article-title":"Intermittent administration of parathyroid hormone 1\u201334 enhances osteogenesis of human mesenchymal stem cells by regulating protein kinase cdelta","volume":"18","author":"Kuo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0270","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3892\/etm.2016.3177","article-title":"Intermittent parathyroid hormone (1\u201334) application regulates cAMP-response element binding protein activity to promote the proliferation and osteogenic differentiation of bone mesenchymal stromal cells, via the cAMP\/PKA signaling pathway","volume":"11","author":"Chen","year":"2016","journal-title":"Experiment. Therapeut. Med."},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbrc.2019.06.084","article-title":"Parathyroid hormone (PTH) promotes ADSC osteogenesis by regulating SIK2 and Wnt4","volume":"516","author":"An","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2021.114669_b0280","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1172\/JCI91699","article-title":"Parathyroid hormone regulates fates of murine osteoblast precursors in vivo","volume":"127","author":"Balani","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0285","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00774-015-0707-x","article-title":"Intermittent PTH treatment can delay the transformation of mature osteoblasts into lining cells on the periosteal surfaces","volume":"34","author":"Jang","year":"2016","journal-title":"J. Bone Miner. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2021.114669_b0290","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031237","article-title":"Regulation of bone remodeling by parathyroid hormone","volume":"8","author":"Wein","year":"2018","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"11","key":"10.1016\/j.bcp.2021.114669_b0295","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jbmr.2556","article-title":"PTH promotes bone anabolism by stimulating aerobic glycolysis via IGF signaling","volume":"30","author":"Esen","year":"2015","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0300","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jbmr.2762","article-title":"Suppression of p38alpha MAPK signaling in osteoblast lineage cells impairs bone anabolic action of parathyroid hormone","volume":"31","author":"Thouverey","year":"2016","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1159\/000477605","article-title":"Endogenous parathyroid hormone promotes fracture healing by increasing expression of BMPR2 through cAMP\/PKA\/CREB pathway in mice","volume":"42","author":"Zhou","year":"2017","journal-title":"Cell. Physiol. Biochem. Int. J. Experiment. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114669_b0310","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bone.2016.08.018","article-title":"BMP signaling is required for adult skeletal homeostasis and mediates bone anabolic action of parathyroid hormone","volume":"92","author":"Khan","year":"2016","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0315","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jbmr.3106","article-title":"The notch ligand jagged1 regulates the osteoblastic lineage by maintaining the osteoprogenitor pool","volume":"32","author":"Lawal","year":"2017","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.bcp.2021.114669_b0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2017.06.027","article-title":"Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes","volume":"103","author":"Zanotti","year":"2017","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0325","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jbmr.3394","article-title":"CYR61\/CCN1 regulates sclerostin levels and bone maintenance","volume":"33","author":"Zhao","year":"2018","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.bcp.2021.114669_b0330","doi-asserted-by":"crossref","unstructured":"G. Zhao, E.W. Kim, J. Jiang, C. Bhoot, K.R. Charles, J. Baek, S. Mohan, J.S. Adams, S. Tetradis, K.M. Lyons, 2020. CCN1\/Cyr61 is required in osteoblasts for responsiveness to the anabolic activity of PTH. J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res.","DOI":"10.1002\/jbmr.4128"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0335","doi-asserted-by":"crossref","first-page":"e0116067","DOI":"10.1371\/journal.pone.0116067","article-title":"MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes","volume":"10","author":"Bao","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/genes8010004","article-title":"miR-203 and miR-320 regulate bone morphogenetic protein-2-induced osteoblast differentiation by targeting distal-less homeobox 5 (Dlx5)","volume":"8","author":"Laxman","year":"2016","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12013-014-0193-0","article-title":"Exploration of the effect of mmu-miR-142-5p on osteoblast and the mechanism","volume":"71","author":"Zhao","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bcp.2021.114669_b0350","doi-asserted-by":"crossref","first-page":"115104","DOI":"10.1016\/j.bone.2019.115104","article-title":"MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis","volume":"131","author":"Kocijan","year":"2020","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bcp.2021.114669_b0355","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1002\/jcp.29454","article-title":"miR-873-3p targets HDAC4 to stimulate matrix metalloproteinase-13 expression upon parathyroid hormone exposure in rat osteoblasts","volume":"235","author":"Malavika","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2018.04.138","article-title":"MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt\/beta -catenin axis: in an animal experiment","volume":"501","author":"Yao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0365","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1002\/jcp.29654","article-title":"Loss of p62 impairs bone turnover and inhibits PTH-induced osteogenesis","volume":"235","author":"Agas","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00223-015-0083-5","article-title":"PTH-induced osteoblast proliferation requires upregulation of the ubiquitin-specific peptidase 2 (Usp2) expression","volume":"98","author":"Shirakawa","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0375","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1038\/s41598-017-05401-1","article-title":"Osteogenic factor Runx2 marks a subset of leptin receptor-positive cells that sit atop the bone marrow stromal cell hierarchy","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0380","first-page":"171","article-title":"Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factormediated angiogenesis","volume":"42","author":"Ding","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0385","first-page":"4","article-title":"Parathyroid function: action of parathyroid hormone in osteocytes, Nature reviews","volume":"13","author":"Greenhill","year":"2017","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0390","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jbm4.10021","article-title":"Parathyroid hormone signaling in osteocytes","volume":"2","author":"Wein","year":"2018","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bcp.2021.114669_b0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nyas.12750","article-title":"Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression","volume":"1364","author":"Li","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2021.114669_b0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diff.2019.05.003","article-title":"Dickkopf1: an immunomodulatory ligand and Wnt antagonist in pathological inflammation","volume":"108","author":"Chae","year":"2019","journal-title":"Different. Res. Biol. Divers."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0405","first-page":"1616","article-title":"PTH promotes rabbit tibial fracture healing via the Notch signaling pathway","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0410","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.M115.685453","article-title":"Hajdu cheney mouse mutants exhibit osteopenia, increased osteoclastogenesis, and bone resorption","volume":"291","author":"Canalis","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114669_b0415","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2016.04.012","article-title":"Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton","volume":"87","author":"Yorgan","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0420","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1152\/ajpendo.00395.2015","article-title":"Canonical Notch activation in osteocytes causes osteopetrosis","volume":"310","author":"Canalis","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0425","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00223-017-0285-0","article-title":"Disruption of the aldehyde dehydrogenase 2 gene results in no increase in trabecular bone mass due to skeletal loading in association with impaired cell cycle regulation through p21 expression in the bone marrow cells of mice","volume":"101","author":"Okuma","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2021.114669_b0430","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2018.02.020","article-title":"Cortical bone loss due to skeletal unloading in aldehyde dehydrogenase 2 gene knockout mice is associated with decreased PTH receptor expression in osteocytes","volume":"110","author":"Tajima","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0435","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41598-017-00503-2","article-title":"A missense single nucleotide polymorphism in the ALDH2 gene, rs671, is associated with hip fracture","volume":"7","author":"Takeshima","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114669_b0440","doi-asserted-by":"crossref","first-page":"115370","DOI":"10.1016\/j.bone.2020.115370","article-title":"Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model","volume":"136","author":"Kosugi","year":"2020","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0445","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1172\/JCI130126","article-title":"Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling","volume":"129","author":"Nishimori","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0450","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00264-018-3994-8","article-title":"The role of autophagy in steroid necrosis of the femoral head: a comprehensive research review","volume":"42","author":"Luo","year":"2018","journal-title":"Int. Orthop."},{"key":"10.1016\/j.bcp.2021.114669_b0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41413-019-0058-7","article-title":"Autophagy in bone homeostasis and the onset of osteoporosis","volume":"7","author":"Yin","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.bcp.2021.114669_b0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.actbio.2016.12.012","article-title":"Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2","volume":"49","author":"Krishnan","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2021.114669_b0465","first-page":"4034","article-title":"Parathyroid hormone (PTH) induces autophagy to protect osteocyte cell survival from dexamethasone damage","volume":"23","author":"Zhu","year":"2017","journal-title":"Med. Sci. Monitor Int. Med. J. Experiment. Clin. Res."},{"issue":"25","key":"10.1016\/j.bcp.2021.114669_b0470","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1074\/jbc.RA118.007312","article-title":"Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism","volume":"294","author":"Sun","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0475","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11914-017-0359-y","article-title":"Parathyroid diseases and T cells","volume":"15","author":"Neale Weitzmann","year":"2017","journal-title":"Curr. Osteoporosis Rep."},{"issue":"8","key":"10.1016\/j.bcp.2021.114669_b0480","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1210\/en.2015-1587","article-title":"Adult-onset deletion of beta-catenin in (10kb)Dmp1-expressing cells prevents intermittent PTH-induced bone gain","volume":"157","author":"Kedlaya","year":"2016","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0485","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s00198-015-3189-8","article-title":"Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients","volume":"26","author":"D'Amelio","year":"2015","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"22","key":"10.1016\/j.bcp.2021.114669_b0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225525","article-title":"The regulation of bone metabolism and disorders by Wnt signaling","volume":"20","author":"Maeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0495","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.7150\/ijms.47273","article-title":"Insensitive to PTH of CD8(+) T cells regulate bone marrow mesenchymal stromal cell in aplastic anemia patients","volume":"17","author":"Li","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0500","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jbmr.2394","article-title":"T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment","volume":"30","author":"Robinson","year":"2015","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0505","doi-asserted-by":"crossref","first-page":"156","DOI":"10.15252\/embr.201744421","article-title":"Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice","volume":"19","author":"Yu","year":"2018","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0510","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jbmr.2191","article-title":"Parathyroid hormone 1\u201384 targets bone vascular structure and perfusion in mice: impacts of its administration regimen and of ovariectomy","volume":"29","author":"Roche","year":"2014","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0515","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00198-015-3460-z","article-title":"Mechanisms of vasodilation to PTH 1\u201384, PTH 1\u201334, and PTHrP 1\u201334 in rat bone resistance arteries","volume":"27","author":"Benson","year":"2016","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0520","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2013.01.028","article-title":"Vasodilation to PTH (1\u201384) in bone arteries is dependent upon the vascular endothelium and is mediated partially via VEGF signaling","volume":"54","author":"Prisby","year":"2013","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0525","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI133473","article-title":"Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota","volume":"130","author":"Li","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0530","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.kint.2020.03.004","article-title":"Gut microbiota orchestrates PTH action in bone: role of butyrate and T cells","volume":"98","author":"Massy","year":"2020","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0535","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.immuni.2018.10.013","article-title":"The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression","volume":"49","author":"Tyagi","year":"2018","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0540","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI86062","article-title":"Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics","volume":"126","author":"Li","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0550","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbrc.2020.02.177","article-title":"Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts","volume":"525","author":"Sun","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114669_b0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2016.08.016","article-title":"Parathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblasts","volume":"92","author":"Heckt","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0560","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jbmr.2698","article-title":"Deletion of the distal Tnfsf11 RL-D2 enhancer that contributes to PTH-mediated RANKL expression in osteoblast lineage cells results in a high bone mass phenotype in mice","volume":"31","author":"Onal","year":"2016","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"key":"10.1016\/j.bcp.2021.114669_b0565","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat. Commun."},{"issue":"52","key":"10.1016\/j.bcp.2021.114669_b0570","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1074\/jbc.RA118.004751","article-title":"Parathyroid hormone(1\u201334) and its analogs differentially modulate osteoblastic Rankl expression via PKA\/SIK2\/SIK3 and PP1\/PP2A-CRTC3 signaling","volume":"293","author":"Ricarte","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114669_b0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2016.05.028","article-title":"Retromer in osteoblasts interacts with protein phosphatase 1 regulator subunit 14C, terminates parathyroid hormone's signaling, and promotes its catabolic response","volume":"9","author":"Xiong","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0580","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.13221","article-title":"N-cadherin restrains PTH repressive effects on sclerostin\/SOST by regulating LRP6-PTH1R interaction","volume":"1385","author":"Yang","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2021.114669_b0585","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bone.2015.07.002","article-title":"Parathyroid hormone regulation of hypoxia-inducible factor signaling in osteoblastic cells","volume":"81","author":"Wong","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2021.114669_b0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fendo.2017.00049","article-title":"CCL2\/monocyte chemoattractant protein 1 and parathyroid hormone action on bone","volume":"8","author":"Siddiqui","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0595","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1038\/s41598-017-15563-7","article-title":"Catabolic effects of human PTH (1\u201334) on bone: requirement of monocyte chemoattractant protein-1 in murine model of hyperparathyroidism","volume":"7","author":"Siddiqui","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114669_b0600","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.12969","article-title":"T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone","volume":"1364","author":"Pacifici","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2021.114669_b0605","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2016.00057","article-title":"The role of IL-17 and TH17 cells in the bone catabolic activity of PTH","volume":"7","author":"Pacifici","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0610","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0615","doi-asserted-by":"crossref","first-page":"e0120164","DOI":"10.1371\/journal.pone.0120164","article-title":"Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice","volume":"10","author":"Choudhary","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0620","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bone.2013.04.017","article-title":"Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro","volume":"56","author":"Choudhary","year":"2013","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bcp.2021.114669_b0625","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1074\/jbc.M115.686576","article-title":"Serum amyloid A3 secreted by preosteoclasts inhibits parathyroid hormone-stimulated cAMP signaling in murine osteoblasts","volume":"291","author":"Choudhary","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0630","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41467-019-14148-4","article-title":"PTH induces bone loss via microbial-dependent expansion of intestinal TNF(+) T cells and Th17 cells","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2021.114669_b0635","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.regpep.2011.05.007","article-title":"Nasal administration of a novel recombinant human parathyroid hormone (1\u201334) analog for the treatment of osteoporosis of ovariectomized rats","volume":"170","author":"Shi","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bcp.2021.114669_b0640","doi-asserted-by":"crossref","first-page":"115326","DOI":"10.1016\/j.bone.2020.115326","article-title":"hPTH(3\u201334)(29\u201334) selectively activated PKC and mimicked osteoanabolic effects of hPTH(1\u201334)","volume":"135","author":"He","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2021.114669_b0645","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cellsig.2017.05.002","article-title":"Translating in vitro ligand bias into in vivo efficacy","volume":"41","author":"Luttrell","year":"2018","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0650","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1615\/CritRevBiomedEng.v40.i5.10","article-title":"Bone tissue engineering: recent advances and challenges","volume":"40","author":"Amini","year":"2012","journal-title":"Crit. Rev. Biomed. Eng."},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0655","doi-asserted-by":"crossref","first-page":"e10367","DOI":"10.1002\/jbm4.10367","article-title":"Optimization of PTH\/PTHrP hybrid peptides to derive a long-acting PTH analog (LA-PTH)","volume":"4","author":"Noda","year":"2020","journal-title":"JBMR Plus"},{"issue":"19","key":"10.1016\/j.bcp.2021.114669_b0660","doi-asserted-by":"crossref","first-page":"e14225","DOI":"10.14814\/phy2.14225","article-title":"Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and beta-arrestin recruitment than teriparatide","volume":"7","author":"Sahbani","year":"2019","journal-title":"Physiol. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0665","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2920","article-title":"Backbone modification of a polypeptide drug alters duration of action in vivo","volume":"32","author":"Cheloha","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114669_b0670","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ol4033978","article-title":"Semisynthesis of peptoid-protein hybrids by chemical ligation at serine","volume":"16","author":"Levine","year":"2014","journal-title":"Org. Lett."},{"issue":"28","key":"10.1016\/j.bcp.2021.114669_b0675","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1039\/C5CC00301F","article-title":"Triblock peptide-linker-lipid molecular design improves potency of peptide ligands targeting family B G protein-coupled receptors","volume":"51","author":"Liu","year":"2015","journal-title":"Chem. Commun."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2021.114669_b0680","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.regpep.2006.12.020","article-title":"Study on preparation and activity of a novel recombinant human parathyroid hormone(1\u201334) analog with N-terminal Pro-Pro extension","volume":"141","author":"Chunxiao","year":"2007","journal-title":"Regul. Pept."},{"issue":"5","key":"10.1016\/j.bcp.2021.114669_b0685","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ejps.2012.09.013","article-title":"Impacts of the N-terminal fragment analog of human parathyroid hormone on structure, composition and biomechanics of bone","volume":"47","author":"Chunxiao","year":"2012","journal-title":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0690","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.peptides.2009.02.013","article-title":"A novel human parathyroid hormone (1\u201334) analog for the treatment of osteoporosis","volume":"30","author":"Feng","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2021.114669_b0695","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2016.11.034","article-title":"Pharmacological effects of a recombinant hPTH(1\u201334) derived peptide on ovariectomized rats","volume":"794","author":"Chunxiao","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114669_b0700","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1021\/acschembio.6b00404","article-title":"Backbone modification of a parathyroid hormone receptor-1 antagonist\/inverse agonist","volume":"11","author":"Cheloha","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"36","key":"10.1016\/j.bcp.2021.114669_b0705","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1021\/jacs.9b05365","article-title":"O-GlcNAc engineering of GPCR peptide-agonists improves their stability and in vivo activity","volume":"141","author":"Levine","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0710","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-Type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0715","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jbmr.2811","article-title":"Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys","volume":"31","author":"Shimizu","year":"2016","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114669_b0720","first-page":"510","article-title":"Physiological roles of parathyroid hormone-related protein","volume":"90","author":"Lai","year":"2019","journal-title":"Acta bio-medica Atenei Parmensis"},{"key":"10.1016\/j.bcp.2021.114669_b0725","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-030-22254-3_13","article-title":"Parathyroid hormone-related protein (PTHrP): an emerging target in cancer progression and metastasis","volume":"1164","author":"Zhang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0730","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1302\/2046-3758.71.BJR-2016-0242.R2","article-title":"Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains","volume":"7","author":"Portal-Nunez","year":"2018","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.bcp.2021.114669_b0735","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2019.04.025","article-title":"Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis","volume":"124","author":"Besschetnova","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2021.114669_b0740","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2018.10.012","article-title":"Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption","volume":"120","author":"Chandler","year":"2019","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bcp.2021.114669_b0745","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-019-04999-4","article-title":"Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia","volume":"30","author":"Chandler","year":"2019","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"3","key":"10.1016\/j.bcp.2021.114669_b0750","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajhp\/zxy022","article-title":"Abaloparatide: a new pharmacological option for osteoporosis","volume":"76","author":"Sleeman","year":"2019","journal-title":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists"},{"issue":"7","key":"10.1016\/j.bcp.2021.114669_b0755","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2014.03.003","article-title":"Tight relationships between B lymphocytes and the skeletal system","volume":"20","author":"Manilay","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114669_b0760","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MED.0000000000000103","article-title":"T-cells and B-cells in osteoporosis","volume":"21","author":"Weitzmann","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0765","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/jbmr.2581","article-title":"PTH signaling in osteoprogenitors is essential for B-lymphocyte differentiation and mobilization","volume":"30","author":"Panaroni","year":"2015","journal-title":"J. Bone Mineral Res. Official J. Am. Soc. Bone Mineral Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114669_b0770","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41467-018-07626-8","article-title":"B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation","volume":"9","author":"Sun","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bcp.2021.114669_b0775","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1517\/17425250802525496","article-title":"Clinical immunotoxicity of therapeutic proteins","volume":"4","author":"Descotes","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:11Z","timestamp":1777399571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":155,"alternative-id":["S0006295221002823"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114669","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid hormone and its related peptides in bone metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114669"}}